Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

NASDAQ:AGIO

Overview | Financials
Company Name Agios Pharmaceuticals, Inc.
Symbol AGIO
Currency USD
Price 45.54
Market Cap 2,590,911,774
Dividend Yield 0%
52-week-range 19.8 - 50.35
Industry Biotechnology
Sector Healthcare
CEO Mr. Brian M. Goff M.B.A.
Website https://www.agios.com

An error occurred while fetching data.

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias;

Related Stocks

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

RadNet, Inc. logo

RadNet, Inc.

RDNT

67.11 USD

Outset Medical, Inc. logo

Outset Medical, Inc.

OM

0.65 USD

Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT

4.61 USD

Innoviva, Inc. logo

Innoviva, Inc.

INVA

19.54 USD

SomaLogic, Inc. logo

SomaLogic, Inc.

SLGC

2.1 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

2.88 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

66.1 USD

Celularity Inc. logo

Celularity Inc.

CELU

2.56 USD

Financials

Numbers are in millions USD

Numbers are in millions USD